Eva Turley, PhD

Eva Turley is Distinguished Oncology Scientist, London Regional Cancer Program, London Health Sciences Centre in London, Ontario, and a Professor in the Department of Oncology, University of Western Ontario, with a cross appointment in the Department of Biochemistry

Her laboratory cloned and characterized RHAMM as a protein that is expressed during tissue stress and injury, and that regulates cell motility.  Her laboratory first identified the peptide sequences in RHAMM that bind to hyaluronan and in collaboration with Dr. Luyt developed inflammation blocking peptides, including AZM-152.  Her laboratory has shown that these peptides reduce fibrosis in experimental models of excisional skin wounds and scleroderma.  Dr. Turley has published over 200 papers that are highly cited in the hyaluronan literature.

Dr. Turley received her PhD at the University of British Columbia and conducted postdoctoral training at Johns Hopkins University.